Cover Image

Complement analysis in the era of targeted therapeutics

Complement immunobiology, and with it complement analysis, has undergone a renaissance in the past decade. Classically, complement analysis was limited number of testing C3, C4 in a routine laboratory with the possible addition of CH50 with all other analysis being performed at only few highly esote...

Full description

Saved in:
Bibliographic Details
Main Authors: Prohászka, Zoltán (Author) , Kirschfink, Michael (Author) , Frazer-Abel, Ashley (Author)
Format: Article (Journal)
Language:English
Published: 20 June 2018
In: Molecular immunology
Year: 2018, Volume: 102, Pages: 84-88
ISSN:1872-9142
DOI:10.1016/j.molimm.2018.06.001
Online Access:Verlag, Volltext: https://doi.org/10.1016/j.molimm.2018.06.001
Verlag: http://www.sciencedirect.com/science/article/pii/S0161589018301846
Get full text
Author Notes:Zoltán Prohászka, Michael Kirschfink, Ashley Frazer-Abel

MARC

LEADER 00000caa a2200000 c 4500
001 1698336799
003 DE-627
005 20230427073147.0
007 cr uuu---uuuuu
008 200515s2018 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.molimm.2018.06.001  |2 doi 
035 |a (DE-627)1698336799 
035 |a (DE-599)KXP1698336799 
035 |a (OCoLC)1341323853 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Prohászka, Zoltán  |e VerfasserIn  |0 (DE-588)1145057268  |0 (DE-627)1006484884  |0 (DE-576)49560240X  |4 aut 
245 1 0 |a Complement analysis in the era of targeted therapeutics  |c Zoltán Prohászka, Michael Kirschfink, Ashley Frazer-Abel 
264 1 |c 20 June 2018 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.05.2020 
520 |a Complement immunobiology, and with it complement analysis, has undergone a renaissance in the past decade. Classically, complement analysis was limited number of testing C3, C4 in a routine laboratory with the possible addition of CH50 with all other analysis being performed at only few highly esoteric laboratories. This diagnostics expanding beyond specialized laboratories is the result of the growing recognition of the role played by complement dysfunction in many more diseases and disorders and the concomitant increase in interest in complement targeting therapeutics. In response, laboratories specializing in complement analysis have joined with the International Complement Society and the IUIS to coordinate efforts to standardize and improve complement testing, ongoing efforts that have already borne fruit. A recognition of the power of complement analysis has brought forward new testing but also realization of the importance of post-draw specimen handling to limit ex vivo activation, as well as the sometimes large difference between testing laboratory results. The increased usefulness of complement analysis and efforts to standardize and expand it means the future is strong for complement analysis. 
650 4 |a CH50 
650 4 |a Complement 
650 4 |a Complement activation 
650 4 |a Complement diagnostics 
650 4 |a Diagnostic techniques and procedures 
650 4 |a Pre-analytic 
650 4 |a Quality control 
650 4 |a sC5b-9 
650 4 |a Standardization 
650 4 |a Therapeutics 
700 1 |a Kirschfink, Michael  |e VerfasserIn  |0 (DE-588)120927152  |0 (DE-627)080974457  |0 (DE-576)292452411  |4 aut 
700 1 |a Frazer-Abel, Ashley  |e VerfasserIn  |0 (DE-588)1210301466  |0 (DE-627)1698336756  |4 aut 
773 0 8 |i Enthalten in  |t Molecular immunology  |d Amsterdam [u.a.] : Elsevier, 1979  |g 102(2018), Seite 84-88  |h Online-Ressource  |w (DE-627)320511332  |w (DE-600)2013448-4  |w (DE-576)252776437  |x 1872-9142  |7 nnas  |a Complement analysis in the era of targeted therapeutics 
773 1 8 |g volume:102  |g year:2018  |g pages:84-88  |g extent:5  |a Complement analysis in the era of targeted therapeutics 
856 4 0 |u https://doi.org/10.1016/j.molimm.2018.06.001  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0161589018301846  |x Verlag 
951 |a AR 
992 |a 20200515 
993 |a Article 
994 |a 2018 
998 |g 120927152  |a Kirschfink, Michael  |m 120927152:Kirschfink, Michael  |d 910000  |d 911600  |e 910000PK120927152  |e 911600PK120927152  |k 0/910000/  |k 1/910000/911600/  |p 2 
999 |a KXP-PPN1698336799  |e 3667392273 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Zoltán Prohászka, Michael Kirschfink, Ashley Frazer-Abel"]},"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"20 June 2018"}],"id":{"eki":["1698336799"],"doi":["10.1016/j.molimm.2018.06.001"]},"physDesc":[{"extent":"5 S."}],"relHost":[{"title":[{"title_sort":"Molecular immunology","title":"Molecular immunology"}],"language":["eng"],"recId":"320511332","note":["Gesehen am 16.01.20"],"disp":"Complement analysis in the era of targeted therapeuticsMolecular immunology","type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"volume":"102","text":"102(2018), Seite 84-88","extent":"5","year":"2018","pages":"84-88"},"pubHistory":["16.1979 -"],"id":{"issn":["1872-9142"],"zdb":["2013448-4"],"eki":["320511332"]},"origin":[{"publisherPlace":"Amsterdam [u.a.] ; Oxford ; Frankfurt, M. [u.a.]","publisher":"Elsevier ; Pergamon Press","dateIssuedKey":"1979","dateIssuedDisp":"1979-"}],"physDesc":[{"extent":"Online-Ressource"}]}],"person":[{"family":"Prohászka","given":"Zoltán","roleDisplay":"VerfasserIn","display":"Prohászka, Zoltán","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Kirschfink, Michael","given":"Michael","family":"Kirschfink"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Frazer-Abel, Ashley","given":"Ashley","family":"Frazer-Abel"}],"title":[{"title_sort":"Complement analysis in the era of targeted therapeutics","title":"Complement analysis in the era of targeted therapeutics"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 15.05.2020"],"recId":"1698336799","language":["eng"]} 
SRT |a PROHASZKAZCOMPLEMENT2020 

Similar Items